France· FR:60591091
LEVIDCEN 1000 mg, granulés enrobés en sachet
A levetiracetam product containing lévétiracétam, registered in France by DESITIN ARZNEIMITTEL (ALLEMAGNE), on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Levetiracetam is registered in 19 of 19 countries.
Countries holding a registration under ATC N03AX14 (levetiracetam), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Levetiracetam · ATC N03AX14
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levetiracetam costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.19 in France to $3.10 in Spain — a ×2.6 gap.
- France: $1.19 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Levetiracetam · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- ES Spain$3.10
- CH Switzerland$2.54
- IT Italy$2.14
- FR France$1.19
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LÉVÉTIRACÉTAM
- Manufacturer
- DESITIN ARZNEIMITTEL (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- N03AX14
- ATC class
- Levetiracetam
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340092799898060 sachet(s) papier aluminium polyéthylèneEUR 105.1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
258 interactions on record for levetiracetam.
Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levetiracetam · interactions on record
258 records
- 50 moderate
- 3 minor
- 164 info
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
41 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levetiracetam in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandLaurak
- SpainLAURAK 1000 MG GRANULADO EN SOBRE EFGNeuraxpharm Spain S.L.U.
- IrelandLarofec 1000 mg film-coated granules in sachetC4 health GmbH
- NetherlandsLarofec 1000 mg filmomhuld granulaat in sachetC4 Health GmbH
- SwedenLevetiracetam Desitin 1000 mg Dragerat granulat i dospåseDesitin Arzneimittel GmbH
- FinlandLarofecC4 health GmbH
- BelgiumLarofec 1000 mgC4 health
- CzechiaDRETACENSandoz s.r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Levebon, Levetiracetam +pharma
- Belgium · Larofec, Levetiracetam A.Forall
- Bulgaria · Levebon, Леветиракон Pharmacons
- Cyprus · Levetiracetam Noridem, Lyberen
- Czechia · Dretacen, Epiletam
- Germany · Levetiracetam 1 A Pharma, Levetiracetam Aaa
- Denmark · Kevesy, Levetiracetam ”1a Farma”
- Estonia · Levetiracetam Zentiva, Normeg
- Spain · Laurak, Levetiracetam Almus
- Finland · Larofec, Levetiracetam 1a Farma
- United Kingdom (Northern Ireland) · Desitrend, Genlev
- Greece · Ession, Kepricet
- Croatia · Levetiracetam Kalceks, Lyvam
- Hungary · Epiletam, Levetiracetam Kabi
- Ireland · Larofec, Levetiracetam Brillpharma
- Iceland · Keppra, Levetiracetam Accord
- Italy · Epitiram, Grifoxina
- Liechtenstein · Keppra, Levetiracetam Accord
- Lithuania · Dretacen, Levetiracetam Kalceks
- Luxembourg · Larofec, Levetiracetam Micro Labs
- Latvia · Levetiracetam Kalceks
- Malta · Levetiracetam Accord, Levetiracetam Aurobindo
- Netherlands · Dretacen, Larofec
- Norway · Keppra, Larofec
- Poland · Cezarius, Lepsitam
- Portugal · Cinaz, Laurak
- Romania · Levetiracetam Accord, Levetiracetam Arena
- Sweden · Levebon, Levetiracetam
- Slovenia · Levetiracetam Kalceks
- Slovakia · Epiletam, Levetiracetam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fef670ca-c8a5-43a9-8fba-d16c4933cb0d GET /v1/drugs/fef670ca-c8a5-43a9-8fba-d16c4933cb0d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60591091",
"date_amm": "2014-10-20",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "LÉVÉTIRACÉTAM",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "granulés enrobé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about levetiracetam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.